BackAcorda Therapeutics Overview

Acorda Therapeutics Research & Development

Research & Development expenses for ACOR.

Quarterly R&D Expenses

$954000.00
↓ 31.17% YoY

As of Mar 31, 2024

Annual R&D Expenses (TTM)

$4.72M
↓ 14.12% YoY

Trailing 12 months ending Mar 31, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin